Safety and efficacy of fedratinib in patients with myelofibrosis previously treated with ruxolitinib: primary analysis of FREEDOM trial.
Gupta V, Yacoub A, Mesa RA, Harrison CN, Vannucchi AM, Kiladjian JJ, Deeg HJ, Fazal S, Foltz L, Mattison RJ, Miller CB, Parameswaran V, Brown P, Hernandez C, Wang J, Talpaz M.
Gupta V, et al. Among authors: miller cb.
Leuk Lymphoma. 2024 Jun 5:1-11. doi: 10.1080/10428194.2024.2346733. Online ahead of print.
Leuk Lymphoma. 2024.
PMID: 38838026